首页|McGill University Reports Findings in Personalized Medicine (Postprandial glucose-management strategies in type 1 diabetes: Current approaches and prospects with precision medicine and artificial intelligence)
McGill University Reports Findings in Personalized Medicine (Postprandial glucose-management strategies in type 1 diabetes: Current approaches and prospects with precision medicine and artificial intelligence)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
New research on Drugs and Therapies - Personalized Medicine is the subject of a report. According to news reporting originating from Quebec, Canada, by NewsRx correspondents, research stated, “Postprandial glucose control can be challenging for individuals with type 1 diabetes, and this can be attributed to many factors, including suboptimal therapy parameters (carbohydrate ratios, correction factors, basal doses) because of physiological changes, meal macronutrients and engagement in postprandial physical activity. This narrative review aims to examine the current postprandial glucosemanagement strategies tested in clinical trials, including adjusting therapy settings, bolusing for meal macronutrients, adjusting pre-exercise and postexercise meal boluses for postprandial physical activity, and other therapeutic options, for individuals on open-loop and closed-loop therapies.”
QuebecCanadaNorth and Central AmericaArtificial IntelligenceDrugs and TherapiesEmerging TechnologiesHealth and MedicineInsulin Dependent Diabetes MellitusMachine LearningNutritional and Metabolic Diseases and ConditionsPeptide HormonesPeptide ProteinsPersonalized MedicinePersonalized TherapyProinsulinType 1 Diabetes
NETL
NSTL
